-
1 Comment
3-D Matrix, Ltd is currently in a long term uptrend where the price is trading 17.7% above its 200 day moving average.
From a valuation standpoint, the stock is 80.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 13.5.
3-D Matrix, Ltd's total revenue rose by 21.8% to $232M since the same quarter in the previous year.
Its net income has increased by 27.9% to $-478M since the same quarter in the previous year.
Based on the above factors, 3-D Matrix, Ltd gets an overall score of 4/5.
| Exchange | TSE |
|---|---|
| Sector | Healthcare |
| Industry | Medical Devices |
| CurrencyCode | JPY |
| ISIN | JP3410730000 |
| Market Cap | 13B |
|---|---|
| Target Price | None |
| Beta | 0.14 |
| PE Ratio | None |
| Dividend Yield | None |
3-D Matrix, Ltd. develops self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7777.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
